skip to primary navigationskip to content


Abcodia is a multi-award winning startup founded in 2010, engaged in the discovery and validation of biomarkers



Our mission is to change the way that biomarkers are developed to allow earlier diagnosis of disease.

Abcodia has exclusive commercial access to a serum biobank which contains samples from over 200,000 female volunteers, 50,000 of whom donated serum annually over a 10-year period.

We aim to partner with diagnostics companies to validate biomarkers as screening tools, pharmaceutical companies to assess disease pathways and academic groups to help discover and commercialise novel biomarkers.

Company Information